Multiclass analysis on repaglinide, flubendazole, robenidine hydrochloride and danofloxacin drugs

Abstract

The drugs under study; repaglinide (Repag), flubendazole (Flu), robenidine hydrochloride (Roben) and danofloxacin (Dano) are antidiabetic, anthelmintic, anticoccidial, and antibiotic drugs. In the present study, they are investigated using electron impact mass spectral (EI-MS) fragmentation at 70eV, in comparison with thermal analyses measurements (TGA/DrTGA and DTA) and molecular orbital calculation (MO). Semi-empirical MO calculation, AM1 procedure, has been carried out on Repag, Flu, Roben and Dano both as neutral molecules (in TA) and the corresponding positively charged species (in MS). The calculated MO parameters include bond length, bond order, charge distribution on different atoms and heat of formation. The fragmentation pathways of Repag, Flu, Roben and Dano in EI-MS led to the formation of important primary and secondary fragment ions. The mechanism of formation of some important daughter ions can be illuminated from comparing with that obtained using mass spectrometer through the accurate mass measurement determination. The MO provides a base for fine distinction among sites of initial bond cleavage and subsequent fragmentation of drug molecules in both thermal analysis and MS techniques. The activation thermodynamic parameters, such as, (activation energy E∗), (enthalpy ΔH∗), (entropy ΔS∗) and (Gibbs free energy ΔG∗) are calculated from the DrTGA curves using Coats–Redfern and Horowitz–Mitzger methods.